1-3 of 3
Weiming Fu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Relapse following discontinuation of imatinib mesylate therapy for FIP1L1/PDGFRA -positive chronic eosinophilic leukemia: implications for optimal dosing

Clinical Trials & Observations
Amy D. Klion, Jamie Robyn, Irina Maric, Weiming Fu, Laura Schmid, Steven Lemery, Pierre Noel, Melissa A. Law, Marilyn Hartsell, Cheryl Talar-Williams, Michael P. Fay, Cynthia E. Dunbar, Thomas B. Nutman
Journal: Blood
Blood (2007) 110 (10): 3552–3556.
https://doi.org/10.1182/blood-2007-07-100164
Published: 2007
Journal Articles

Systemic Mastocytosis with Eosinophilia: A Novel Diagnostic Approach To Distinguish Imatinib-Resistant Kit D816V-Associated Mast Cell Disease from Imatinib-Sensitive FIP1L1/PDGFRA-Associated Hypereosinophilic Syndrome.

Todd M. Wilson, Irina Maric, Amy D. Klion, Cem Akin, Melody Carter, Weiming Fu, Jennifer Stoddard, Linda Scott, Arnold Kirshenbaum, Michael Fay, Thomas B. Nutman, Pierre Noel, Dean D. Metcalfe, Jamie Robyn
Journal: Blood
Blood (2006) 108 (11): 2683.
https://doi.org/10.1182/blood.V108.11.2683.2683
Published: 2006
Journal Articles

Detection of c-Kit Mutation in Peripheral Blood vs. Bone Marrow Aspirates in Patients with Systemic Mastocytosis: Comparison Study of Pathological and Clinical Laboratory Findings in Patients with and without Detectable c-Kit Mutation in the Peripheral Blood.

Irina Maric, MD, Jamie Robyn, M.D., Ph.D., Weiming Fu, M.D., Jennifer Stoddard, Dean D. Metcalfe, M.D., Pierre Noel, M.D.
Journal: Blood
Blood (2006) 108 (11): 3596.
https://doi.org/10.1182/blood.V108.11.3596.3596
Published: 2006